• Year Founded: 1999
• Headquarters: Shenzhen,China
• Estimated Employees: 3585
• Product Lines:
  • Genetic Sequencer
  • Clinical Testing
  • In Vitro Diagnostic
  • Human Genetics Research
  • Animal and Plant Research
  • Microbiology Research
  • Epigenetic Research
  • Disease Research
• Products:
  • DNBSEQ-T7 Genetic Sequencer
  • MGISP-960 High-throughput Automated Sample Preparation System
  • MGIUS-R3 Remote Ultrasound Diagnostic System
  • Neonatal testing,Women's health testing,Prenatal testing
  • Pre pregnancy testing,Genetic Tumor Gene Detection
  • Cervical cancer screening
  • Non-invasive DNA paternity testing during pregnancy

Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV

DNBSEQ-T7 Genetic Sequencer

MGIUS-R3 Remote Ultrasound Diagnostic System

MGISP-960 High-throughput Automated Sample Preparation System

Founded in 1999, BGI is one of the world's leading life science and genomics organizations. BGI’s mission is to use genomics to benefit mankind and to be a leader in the era of life sciences. BGI follows a genomics development model of “research, production and application”. With businesses in more than 100 countries and regions around the world, BGI has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation and judicial services. At the same time, BGI provides equipment, technical support and solutions for the needs of national economies and people's livelihoods, such as precision medicine and precision health. BGI is committed to applying its genetic and technological achievements to real world settings in order to realize the dream of trans-omics for a better life.

BGI has mapped out the genomes for cancer cells, plants, insects, humans and the giant panda. It is now working to catalogue the genes of more than 2,000 families with autistic children. B.G.I. aims bring the cost under $1,000, at which point it could be incorporated into normal medical care.

By July 2018, BGI has applied for 2,694 domestic and international patent applications, including 429 PCT (Patent Cooperation Treaty) patents.
BGI has been granted 685 invention patents and 195 overseas patents.
The number of new patent applications per year from 2015-2017 is 194，175，443.